Tony Maida joins AHLA for their podcast series, “Speaking of Health Law.” Tony and speakers join for a conversation covering value-based Anti-Kickback Statute safe harbors and Physician Self-Referral exceptions.

Learn more and listen here.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, and Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, are joined by Brown Gibbons Lang & Company’s own John M. Tiedmann Jr., Director and senior member, and J. Kyle Brown, Managing Director and senior member of their Healthcare & Life Sciences team. They discuss the current state of the deal market and deal flow and provide insight into the most active spaces in healthcare and the macro market forces affecting opportunities this year.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, conducts an intimate interview with PT Solutions Chief Strategy Officer(and former Private Equity Sponsor) Matt Beck-Goolsby. Together, they provide an overview of the PT market and discuss:

• How PE-backed PT assets can add value to hospitals
• The labor market and supply and demand imbalance within PT
• Lessons learned from failed PT deals
• Tech-enabled advantages
• Future opportunities within the PT market

In Season 2, Episode 15 of Driving the Deal, host Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by FSG’s Health Policy Senior Associate Holly Stokes and Assistant Vice President Hope Amsterdam. Together, they provide an overview of the 2022 midterm election results and discuss which legislative issues we can expect taken up in 2023. During this episode, they talk about:

• Upcoming end-of-year legislation Midterm implications for the Inflation Reduction Act of 2022 and drug pricing
• Future telehealth and behavioral health legislation
• The split US Congress and how it will affect past and future legislation
• The impact election results will have on the fertility space post Dobbs

In this, the second part of an insightful conversation about the challenges and trends facing the executive compensation committee, Michael Peregrine, Tim Cotter, and Ralph DeJong address (i) considerations for special compensation arrangements, (ii) the role of discretion in business judgment and goal-setting for the coming year, and (iii) how the committee can best prepare for and respond to media questions about CEO compensation in advance—as well as a host of additional challenges facing the committee, including:

• Performance measures for ESG themes.
• Should organizational structural considerations be a committee concern?
• Revisiting the committee charter to ensure continued relevance.
• Key takeaways from recent committee meetings.

In the 14th episode of Season 2: Driving the Deal, Krist Werling, McDermott Will & Emery partner and co-head of the Firm’s private equity practice, and Brian Fortune, senior managing director at Farragut Square Group, recap McDermott’s 2022 HPE New York event. Together, they share key themes from the conference and discuss current healthcare deal market highlights, including:

• The trends slowing down large deals while also powering activity in the low and middle market
• The current debt market, outlook for 2023 and potential financing opportunities
• A look at the activity within the pharmaceutical services space
• An overview of recent CMS rulemaking (i.e., PFS, OPPS, home health and ESRD)
• The future of dealmaking as we head toward a potential recession